HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
17.96
+1.21 (7.22%)
Nov 20, 2024, 4:00 PM EST - Market closed
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $3.07 billion as of November 21, 2024. Its market cap has decreased by -10.30% in one year.
Market Cap
3.07B
Enterprise Value
2.36B
1-Year Change
-10.30%
Ranking
Category
Stock Price
$17.96
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $3.07B, an increase of 92.06%. That is a compound annual growth rate of 7.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.13B | -0.23% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amedisys | 2.95B |
| Xenon Pharmaceuticals | 2.95B |
| Merus | 2.94B |
| Vera Therapeutics | 2.89B |
| Surgery Partners | 2.88B |
| Amicus Therapeutics | 2.84B |
| LivaNova | 2.84B |
| Warby Parker | 2.78B |